Skip to content

Opening book details…

About this Medicine article

Pharmacokinetics, safety, tolerability and immunogenicity of FKB327, a new biosimilar medicine of adalimumab/Humira, in healthy subjects by Puri, Adeep; Niewiarowski, Andrew; Arai, Yasumasa; Nomura, Hideaki; Baird, Mark; Dalrymple, Isobel; Warrington, Steve; Boyce, Malcolm is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Puri, Adeep; Niewiarowski, Andrew; Arai, Yasumasa; Nomura, Hideaki; Baird, Mark; Dalrymple, Isobel; Warrington, Steve; Boyce, Malcolm
Publisher
John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley; Research Square (ISSN 0306-5251)
Published
2017
Language
EN
Field
Medicine (Health Sciences)

More by Puri, Adeep; Niewiarowski, Andrew; Arai, Yasumasa; Nomura, Hideaki; Baird, Mark; Dalrymple, Isobel; Warrington, Steve; Boyce, Malcolm

Browse all works by Puri, Adeep; Niewiarowski, Andrew; Arai, Yasumasa; Nomura, Hideaki; Baird, Mark; Dalrymple, Isobel; Warrington, Steve; Boyce, Malcolm